.png)
TECHNOLOGY
Product Pipeline
Neuraptive is advancing a pipeline of investigational therapies and technologies for peripheral nerve injury.
NTX-001 | PEG-Fusion
Phase 3 Clinical Development
NTX-002 | Bioresorbable Nerve Stimulation
Preclinical Development
NTX-001
A novel nerve fusion system for repairing severed peripheral nerves.
NTX-001 is a kit comprised of nerve fusion technology and a specialized device intended for use during surgical nerve procedures.
The technology in our kit is designed to restore electrical signaling across a severed peripheral nerve intra-operatively, thus preventing Wallerian degeneration in axons distal to injury.
NTX-001 is investigational and has not been approved or cleared by the FDA. Its safety and effectiveness in humans have not been established.
NTX-002
Bioresorbable Nerve Stimulation
An investigational bioresorbable wireless nerve stimulation device for peripheral nerve injury.
NTX-002 is in preclinical development for transected nerves and crush injuries.
The device is designed to deliver targeted electrical stimulation to an injured nerve and to resorb over time, so that surgical support nerve regeneration so that surgical removal is not required.
NTX-002 is investigational and has not been approved or cleared by the FDA. Its safety and effectiveness in humans have not been established.